Carecloud Inc Stock Price, News & Analysis

CareCloud (Nasdaq: CCLD) has launched its AI Center of Excellence (AI CoE), starting with 50 AI engineers, data scientists, and healthcare experts, with plans to expand to 500 AI professionals by Q4 2025. The initiative aims to become the world's largest dedicated healthcare AI center.

Operating under a dual-shore model, the self-funded AI CoE leverages CareCloud's 25 years of clinical and financial data to develop proprietary healthcare AI solutions. The center focuses on developing intelligent models for clinical workflows, revenue cycle processes, and decision support, while streamlining operations through automation.

Key focus areas include:

• Proprietary healthcare AI model development
• Automation of clinical documentation and claims management
• Predictive analytics for reimbursement risks
• AI-driven patient engagement enhancement
• Integration of AI across EHR and RCM platforms

CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider, has scheduled its first quarter 2025 financial results announcement for May 6, 2025, before market opening. The company will host an investor conference call at 8:30 a.m. Eastern Time on the same day.

Investors can access the live webcast and presentation slides at ir.carecloud.com/events, or join via audio-only option by dialing 201-389-0920. A replay will be available approximately three hours after the call's conclusion, accessible through the same link or by dialing 412-317-6671 with access code 13753440.

CareCloud (Nasdaq: CCLD) has announced its participation in the 15th Annual LD Micro Invitational at the Westin Grand Central Hotel in New York on April 9-10, 2025. The healthcare technology solutions provider will deliver its corporate presentation on April 10, 2025 at 3:30 p.m. ET.

During the event, management will showcase the company's:

• Recent developments and innovative solutions
• Strategic growth initiatives
• Two recent acquisitions
• Conversion of Series A preferred stock
• Significant profitability growth throughout 2024

The team will also engage in one-on-one meetings with institutional and individual investors to discuss growth opportunities and value creation strategies.

CareCloud (NASDAQ: CCLD) has announced the acquisition of RevNu Medical Management, an audiology-focused revenue cycle management company based in Westminster, California. This marks CareCloud's second acquisition in 31 days, following the MesaBilling deal.

RevNu's founder Clay Gililland, who owns over 30 hearing health clinics in Southern California, will integrate with CareCloud to leverage their technology and automation capabilities. Daniel Davis, former RevNu CEO, will lead CareCloud's new hearing healthcare division as President.

The acquisition targets the U.S. audiology market, which includes approximately 24,000 employed audiologists and hearing aid specialists, with annual hearing aid spending exceeding $5 billion. The segment remains minimally penetrated by outsourced RCM vendors. The acquisition is expected to be accretive within 90 days, with consideration paid quarterly based on retained revenue.

CareCloud (Nasdaq: CCLD) announced an expanded partnership with Alpine Ear, Nose & Throat PC, a Colorado-based otolaryngology group. Following their existing revenue cycle management (RCM) collaboration, Alpine ENT has implemented CareCloud FrontDesk Assist, a front-office solution aimed at streamlining operations.

Alpine ENT, with 24 providers across three Northern Colorado locations, reported improvements in operational efficiency since implementing FrontDesk Assist, including reduced patient wait times and streamlined appointment scheduling. The solution supports critical front-office functions such as referral management, surgery estimates, and prior authorizations.

The practice, which offers ENT services, audiology, vestibular therapy, and allergy care, has experienced measurable gains in productivity and patient engagement through this expanded partnership. FrontDesk Assist is now available nationwide to healthcare practices across all specialties.

CareCloud (CCLD) has announced its Board's declaration of monthly cash dividends for March and April 2025 for its Series A and Series B Preferred Stock. Series A Preferred Stock holders will receive dividends at 8.75% per annum of the $25.00 per share liquidation preference ($2.1875 per annum per share), plus an additional 2.25% payment for oldest dividend due. Series B Preferred Stock holders will receive dividends at 8.75% per annum ($2.1875 per annum per share).

The dividends are cumulative and payable monthly on the 15th of each month. Record dates are set for the last day of each calendar month, with payments made on the next business day if the 15th falls on a non-business day.

CareCloud (NASDAQ: CCLD) reported strong financial results for full year 2024, marking a significant turnaround with a GAAP net income of $7.9 million compared to a $48.7 million loss in 2023. The company achieved revenue of $110.8 million and increased Adjusted EBITDA by 56% to $24.1 million.

Key highlights include a 244% increase in free cash flow to $13.2 million and strong Q4 2024 performance with $3.3 million in net income. The company completed strategic financial moves including converting 3.5 million Series A Preferred Stock into 26 million common shares, reducing annual dividend burden by $7.7 million, and fully repaying its Silicon Valley Bank credit line.

Looking ahead to 2025, CareCloud projects revenue of $111-114 million, Adjusted EBITDA of $26-28 million, and EPS of $0.10-0.13. The company attributes its improved performance to AI-driven innovation and operational efficiency.

CareCloud (Nasdaq: CCLD) has announced its intention to voluntarily delist its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (CCLDP) from the Nasdaq Global Market. This decision follows a mandatory conversion of Series A Preferred Stock into common stock, where each share was converted into 7.3358 shares of the company's common stock. The conversion excluded 'material shareholders' who owned at least 100,000 shares of Series A Preferred Stock.

The company plans to file a Form 25 with the SEC around March 21, 2025, with the delisting expected to become effective by March 31, 2025. The delisting is being initiated as the security no longer meets Nasdaq's continued listing requirements following the conversion.

CareCloud (CCLD) has announced the mandatory conversion of its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock into Common Stock. The conversion, effective March 6, 2025, at 4:01 p.m. Eastern Time, will convert each preferred share into 7.3358 shares of Common Stock, including all accumulated and unpaid dividends.

This strategic move will eliminate approximately $7 million in annual dividend obligations, allowing the company to reinvest capital in growth initiatives. According to Norman Roth, Interim CFO, the conversion will result in a cleaner capital structure and enhanced flexibility for shareholder value creation.

Shareholders owning at least 100,000 preferred shares as of the Mandatory Exchange Date retain the right to object to the conversion. Fractional shares will be rounded up to the next whole share, and dividends on converted shares will cease to accrue on the conversion date.